Deep Parasternal Intercostal Plane Block Versus Erector Spinae Plane Block in Pediatric Cardiac Patients Undergoing Primary Repair of Septal Defects Via Median Sternotomy
Launched by AIN SHAMS UNIVERSITY · Mar 7, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Pediatric cardiac surgery involving median sternotomy can be associated with significant postoperative pain. Poorly controlled pain following cardiac surgery has been shown to be a risk factor for increased morbidity, including severe cardiopulmonary dysfunction, hypercoagulability, and immunosuppression.
Post-operative pain management, which provides effective analgesia, minimizes side effects and contributes to enhanced recovery after surgery, is a unique challenge in the pediatric cardiac surgery population. The ideal post-operative analgesic regimen would enable early separation from m...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients with acyanotic heart disease
- • Patients with septal defect undergoing primary repair
- • ASA Ⅰ and Ⅱ
- Exclusion Criteria:
- • Patient's guardian refusal of procedure or participation in the study.
- • Patients with hemodynamic instability
- • Preexisting infection at the block site
- • Allergy to local anesthetics
- • Psychiatric illness
- • Abnormal coagulation profile
- • Preoperative ejection fraction less than 35%
- • Recurrent ventricular arrhythmias
- • Emergency Surgery
- • Redo surgeries
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported